Multiple Myeloma - Survival Rate Statistics by Hospital
  • Home
  • Higher Risk Myeloma
  • Myeloma Blog
  • Myeloma Specialists Listing
  • Doctor Submissions
  • Contact Us

Dr. Craig Hofmeister, Dr. Jan Moreb, and Dr. Parmeswaran Hari are Multiple Myeloma Heroes providing free second opinions for a patient in Poland,  Kosovo, and Racine, Wisconsin -  Updated 4/10/2013

4/5/2013

2 Comments

 


To help promote Mulitple Myeloma Awareness month I had asked a number of doctors that are excellent multiple myeloma specialists  if they would contribute a second opinion for a patient anywhere in the world who was in need of an experts assistance    Dr Hofmeister of The James at Ohio State University, Dr. Moreb of Shands at the University of Florida, and Dr. Parameswaran  Hari of the Medical College of Wisconsin volunteered to participate.  To me they are not only excellent multiple myeloma specialists, but selfless humanitarians as well.   I had asked patients to provide their situation in writing to the [email protected] and the most compelling would be chosen April 1st.  So what was the outcome.  
___________________________________________________________________________

Picture
Dr. Jan Moreb - Professor Bone Marrow Transplant Program, University of Florida, Department of Medicine


This is letter from Kosovo which was selected, and Dr. Moreb has already started the discussion with Arlinda.


Dear Dr. Moreb,
 
Accidentaly I have seen on the internet the link: http://myelomasurvival.com/1/post/2013/03/multiple-myeloma-awareness-month-and-the-world-renowned-myeloma-specialist-dr-hofmeister-is-providing-a-free-second-opionion.html , where I can be addressed for a second opinon on Multiple Myeloma which recently was the medical diagnosis for my father- 64 years old. We live in Kosovo a new country in South East Europe and with many deficits in the health system.
 
Please, if you are interested I can send you the medical report in English translated for an second opinon on the treatment, options of the treatment, world centers for the treatment and prognosis of this illness.
 
Hope to hear from you soon.
 
Best regards,
 
Arlinda

____________________________________________________________________________


Picture
Dr. Craig Hofmeister - Assistant Professor of Internal Medicine at Ohio State University Medical Center


This is the letter from Poland which was selected, and Dr. Hofmeister has already contacted Edyta.



Dear Doctor Hofmeister,

I am writing this email to you as my uncle Stanislaw has been diagnosed with multiple myeloma.
He is 64 and full of life. He lives in the small village in south east corner of Poland (Rzeszow is the nearest town) where the medical care is really poor and especially in this part of Poland we do not have any good specialists who deal with this illness. 
He is very lovely person. He is my God father and I love him dearly. He is very brave and decided to take this illness as destiny and God's will and accept that he can die soon but I would like to help him and get second opinion about his illness and methods of treatment he should undertake. He is under care of one doctor but I am not sure if the proposed treatment is the best for him and maybe there is more that can be done for him. 
Would you be please so kind to reply to my email so I can send you his full results and what kind of treatment has been offered to him so far.
I would appreciate your reply and your good heart help in this case. 
Please help him.
Many thanks 

Kind regards, 

Edyta Rybak

____________________________________________________________________________

Picture
Dr. Parameswaran Hari- Section Head and Clinical Director, Bone Marrow Transplantation and Associate Professor of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin


This is the letter from a 30 year old with no insurance from Racine, Wisconsin which was selected, and Dr. Parameswaran Hari  has already contacted Nicholas.


Dear Doctor Parmeswaran Hari,

Dr. Hari, please save my life.  I have a wonderful support system and a good job that's fulltime. I never saw this coming. I have been with my girlriendf for 5 years now and we planned on having a long and fun life together.. My life seemed invincible until 1 year ago on a spring night. I was at a friends party and we were all having such a great time. My friend decided to get on his trampoline and so I followed suit. After a few drinks this was obviously not a good idea. My friend jumped off of his trampoline. I did the same only I landed onto my shoulder HARD and It hurt. I put off seeing the doctor for a few days to see if the pain would eventually go away. It's when I was in the shower and heard a pop followed by my cry of pain that I knew something was seriously wrong. My girlfriend and I went to see the doctor. The Doctor took the usual x-rays. He never acted surprised or suspicious at what he saw, why would he? He has seen so many broken bones in his time. It wasn't until he came into the office after I waited and he said he noticed "something interesting was going on in there and he'd like to take a look at it with an MRI. MRI's cost tons of money, especially without insurance. I politely declined as I explained all my finances would be tied up into this injury as it is. After I healed up I was released and back to a normal life.

Everything was going fine with minor pain. On a saturday afternoon our manager had asked us to remove some donor beds (I work in a plasma center) so that a crew could come in to wax the floors that night. I knew I had been feeling pain for a few weeks in my neck/shoulder area so I really didn't want too. I figured it must have been from repetative motions at work. But I did and this decision changed my life dramatically. As my coworker and I lifted a donor bed I felt a sharp pain in my neck. I could barely move my arm as it was so excruciating. I shyly let my manager know I hurt myself. She wanted me to go to Concentra health care the day after but they were closed because it was a sunday. The first available day for concentra clinic to be open I was sent there.  It was there that I met Doctor Krieger.  They took x-rays and began putting me into physical therapy. a day later.  After a few days or so there was very little progress. I was frustrated because I really wanted to get back into swimming but I couldn't even lift my arm to chest level.  I am a big Michael Phelps fan and always joked I was training for the Olympics.  About 4 days later I saw doctor Krieger at Concentra again. to have my x-ray impressions read to me  He walked me into the physical therapy room and had me lift a few weights to test my limits. He then led me into his office and told me I might want to sit down for this. I could tell he was nervous and wasn't sure how he would say what he was about too. I thought to myself right away, "oh crap, because of my past medical issues with my shoulder workers comp won't cover it". I rreally wish that was the issue but as we all know it wasn't. Even as I write this I have tears in my eyes remembering this day like it was just yesterday. He started to read the radiologist's report explaining, "a soft tissue mass was shown with associated destruction of the second left rib". Not understanding this he then said the words I thought Id never hear, "this could be cancer". Tears streamed down my face as I sat back in my chair floored by this horrible news. My whole world was just flipped upside down. My heart sunk. He said he was very sorry and he'd help me as a resource in anyway he could. I left that day with a broken heart and spirit. I only lived 3 blocks away from Concentra and I remember it was the longest coldest winter walk home of my life. I then called work in tears explaining I needed the day off. The second person I called was my girlfriend on her lunch period. She has been my comforter and support in all of this. She was a little stressed but she took the news quite well and I was impressed by her composure. We both kept thinking it may be something to do with my scoliosis or various other possibilities. After a couple of weeks of visiting the Dr. Krieger at Concentra he decided that physical therapy wasn't working due to my underlying medical issues.  He said we would have to end workers comp. because he has to be fair with them.  He let me work with him a few more days.  I wanted to believe that the physical therapy was working but it wasn't.  He wrote me an order for an MRI and sent me to P.D.I. in Franklin.  It was there that I met Dr. Robert G. Wells.  I had a pretty good idea of his credentials because I googled him.  He is a well respected radiologist within the medical community.  He was also one of the nicest gentleman I have ever met and quite possibly saved my life.  I was led to the area where the MRI would be performed.  Never having been in one I can now state that I am not claustrophobic.  After what seemed like forever I was finally done with the MRI scan.  He then decided to do a CT scan.  He confirmed that I had a tumor and clearly explained that it is malignant from what he can see and set a follow up appointment for a core needle biopsy. He did all this knowing I had no insurance but I paid what I could in cash.  I saw Dr. Krieger again and he set up an oder for the needle biopsy with Dr. Wells.  The biopsy was not painful at all and we had a good conversation while he was working away. The core needle biopsy confirmed that I had a cancer called plasmacytoma. When I got the call from Doctor Krieger I actually kind of laughed at the irony because I work at the plasma center.  He said it is an incredibly rare cancer. I walked to his office to pick up my pathologist report.
 
I did everything I could researching this new thing called plasmacytoma.  Hours upon hours on google were spent.  I learnt that it is very slow progressing and is usually delt with by a few zaps of radiation or monitored. I also learnt it is more prominent in males over the age of 55! I also discovered it was not fatal so long as it is treated immediately. After a few days I talked with the doctor at the plasma center and he recommended I go to the Aurora Oncology Clinic right across the parkinglot from Concentra because his friend Doctor Malone worked there. I met doctor Ruggeri because Dr. Malone has been so backed up with patients,  He was a very nice enthusiastic gentleman. He then looked at all the reports forwarded from doctor Robert Wells office.  He explained to me what exactly plasmacytoma was as well as multiple myeloma.  A lot of information I already knew from my research.  After he got the files from Dr. Wells office he began reading a few reports.  It is when he got to the CT scan impressions that left me with another surprise in my lap. This was the first time I had them read to me. He read, "several abnormal leaions in the right clavical, left clavical, right and left second ribs, and the spine were apparent." I knew from research online that this could mean I have multiple myeloma which is considerably more dangerous than plasmacytoma and is fatal. I also knew I was a rare case.  More importantly I knew that there was no cure for this.  

Here I was only 30 looking at cancer that generally is diagnosed in patients over the age of 50. A skeletal survey (20 x-rays or so), a bone marrow biopsy, blood work, and a PET scan were all done. The bone marrow biopsy was considerably more painful than the core needle biopsy but not as bad as people make it out to be. All tests verified that I had multiple myeloma. The good news is that the calcium level in my blood is low and there's no damage to my kidneys. The cancer was caught early enough before ANY apparent damage to my organs has begun. The bad news, as revealed by the CT Scan is that I have abnormal cell activity in both clavicals, my left femur right above the knee, both ribs, and a small hole in my skull right in the center. Talk about a third eye!  Doctor Ruggeri said "it's like I have plasmacytomas in multiple areas".  I didn't understamd if I had multiple myeloma or not.  So he said he would say it is.  I asked how long do I have.  Doctor Ruggeri said he would try to get me 10 years at least. 10 years at the age of 30! That is definitely not enought time! I have so much more I want to do in my life. I want to travel and see so many parts of the world.  Eventually I wanted to go to school and pursue a career. I have so many more books I wanted to read and skills to learn. I want to experience ALL life has to offer and 10 years just isn't enough. I love my girlfriend with all my heart and I want to live with her and marry her, (provided her father gave his blessings). We just moved in together 3 months ago. I want to know what it is like to spend the rest of my life with her but definitley for more than 10 more years. Ever since my diagnosis I have had so many sleepless nights wanting to stay up as late as I could just so my days last longer. It's like when you sleep everything goes by so fast.  I know that if I have any hope of living long enough to see a break through in cancer research then I need the proper care.  I just want to live my life as normal as I can.  I don't want a death sentence at the age of 30.  So can you please help save my life Dr. Hari? 

Best Regards,



Nicholas Avery


__________________________________________________________________________________________________

Dr. Hofmeister, Dr. Moreb,  and Dr. Hari, we at www.myelomasurvival.com thank you for your paticipation, and we thank Edyta,  and Arlinda, for the love and caring that they have shown for their family members  in need.  Nicholas, your letter was so compelling  and moving.    May God Bless your myeloma journey, and we will continue to follow up with Edyta, Arlinda, and Nicholas to see how their myeloma journeys unfold. 


Best Regards and toghether we will SAVE LIFE/ Gary Petersen [email protected]
2 Comments

Multiple Myeloma Awareness Month and the world renowned Myeloma Specialists Dr. Hofmeister and Dr. Jan Moreb are providing a FREE second opionion  

3/20/2013

2 Comments

 
Multiple Myeloma - Save Yourself!!!!  Dr. Hofmeister, of The James Cancer Center at Ohio State University, as part of Multiple Myeloma Awareness Month, has offered to provide a free second opinion over the phone to a worthy myeloma patient anywhere in the world.  As I have stated time and time  again a multiple myeloma specialist can double and triple your life expectancy and survival rate.   All that is required is that your provide an email to [email protected] outlining the reasons you might have a need of a second opinion from a multiple myeloma specialist.  We will then determine the patient  most in need.  That it all that is required.  Once you have been chosen we will require that you forward all of your required test results to Dr. Hofmeister for his review.   If I find that there is a siginificant need I will pay Dr. Hofmeister from my own pocket for one additional second opinion to help "SAVE LIFE".  Dr. Jan Moreb of The Shands at the University of Florida has also generous in providing a consult.  Dr. Moreb's myeloma program has shown exceptional life expectancy and survival rates.   Any other people who would like to contribute can contact me as well.
Picture
Dr. Craig Hofmeister has been a member of the Blood and Marrow Transplant Program at The James since 2006. He received his Bachelor of Science in Biochemistry and Molecular Biology from Brown University and his Medical Degree from The Ohio State University.  He completed his internship, residency and fellowship training at Loyola University Medical Center and Loyola Cardinal Bernardin Cancer Center in Illinois. Board Certified in Internal Medicine, Hematology and Medical Oncology, his clinical and research interests include multiple myeloma and blood and marrow transplantation.  Dr. Hofmeister is an assistant professor of Internal Medicine at Ohio State University Medical Center.

Picture
Dr. Jan Moreb - Professor Bone Marrow Transplant Program, University of Florida, Department of Medicine. Dr Moreb is a physician scientist and is board certified in Internal Medicine and
Hematology.  He is well published with a focus on multiple myeloma 
and stem cell transplantation. He is a member of many medical 
societies including the American Society of Hematology, the 
American Association for Cancer Research, and the American 
Society for Blood and Marrow Transplantation.  His program at 
the University of Florida was nicely presented in an article you can read if you just CLICK HERE. His training includes:
MD - Hebrew University Hadassah Medical School, Jerusalem, Israel
Internship - Hadassah University Hospital, Jerusalem, Israel
Hematology Residency - Hadassah University Hospital, Jerusalem, Israel   
Resident and Chief Resident(Internal Medicine) - Shaare-Zedek University Hospital, Israel
Oncology Hematology Fellowship -  University of Florida, College of Medicine, Gainesville, FL


Thank you Dr. Hofmeister and Dr. Moreb for your generous donations.  Dr. Hofmeister's exact donation is even better for anyone who may be able to visit his facility in Columbus, Ohio.  Dr. Hofmeister states: " Happy to review someone's records and talk with them by phone as a second opinion.  If they come to Ohio State for a 2nd opinion, there insurance will be billed for the labs, the nurse's time, etc.  That said if the patient has no resources, we see patients without insurance and have social workers that will handhold the patient through medicaid and all that "

Dr. Moreb's response to my request was " I will be happy to participate.  Thank you for doing this."   Dr. Moreb, we thank you for your selfless generosity!


However, if you are not chosen, you can still get a second opinion on line from Dr. Hofmeister for  a very reasonable price if you go to the web site: https://2nd.md/disease/multiplemyeloma .  Consults on this site are very reasonably priced and run from $100 to $250 for a 20 minute consult.  A consult  with Dr. Hofmeister could  just SAVE LIFE! Maybe yours! 

And as always, may God Bless your multiple myeloma jouney /Gary Petersen

2 Comments

Working while Living with Multiple Myeloma - Cure Panel Broadcast March 20, at 6:00pm

3/11/2013

0 Comments

 
***Now that the Panel Broadcast is over you can listen to it if you just CLICK HERE.***
You are working and have been diagnosed with multiple myeloma.  You are generally younger(see graph below) and as such have a longer  life expectancy and survival rate, and will be in the workforce for a long time.  Thank God!  If your disease allows you to work, what are your challenges?   How are you viewed in the workplace? Can you be fired?  What are your promotional opportunities?.  Will anyone else hire you?  Does your employer have adequate insurance?  What if you use all you family leave for treatment, can you be terminated?  There are a lot of questions that come up that are not typical for the average patient who is age 70, retired and on Medicare, with supplemental drug insurance, and hopefully Medicare Gap Insurance. You can find more information on the meeting by CLICKING HERE,  or to just sign up you can CLICK HERE.
Picture
Matt Goldman is the co-host of the program with Priya Menon of Cure Talk and they will have two speakers.

Anya Prince, Staff Attorney, Cancer Legal Resource Center  Anya Prince is a Staff Attorney with the Cancer Legal Resource Center.  The Cancer Legal Resource Center (CLRC) is a national, joint program of the Disability Rights Legal Center and Loyola Law School Los Angeles. The CLRC provides free information and resources on cancer-related issues to cancer survivors, caregivers, health care professionals, employers, and others coping with cancer.

Amy Garofalo -  She started her own small Medical Transcription Company in 1996 and she also works for Middlesex Hospital as their Transcription Department Coordinator. Amy was diagnosed with Multiple Myeloma in April of 2011 – 7 months after starting her new job with Middlesex Hospital. She had a stem cell transplant, after many setbacks, on April 18, 2012. Her husband has set up a CaringBridge site for her at caringbridge.org/visit/amygarofalo where she writes about her journey with Multiple Myeloma.

For those patients who are are still in the work force, or struggling to continue in the work force, or feel trapped into working because you need the insurance, this is a great opportunity to hear from people in the same situation, and to ask your questions of the panel members on line during the broadcast.  

Best Regards and as always may God Bless your myeloma journey./ [email protected]

***SAVE LIFE!!!  March is Multiple Myeloma Awareness month, and four links that will help in your awareness and to help others who have myeloma can be seen if you just click: Link1, Link2, Link3 and Link 4. Also I believe reading www.myelomasurvival.com will help as well.***


0 Comments

Save Life!!! March is Multiple Myeloma Awareness Month

3/5/2013

5 Comments

 
The IMF(International Myeloma Foundation) has designated March as "Multiple Myeloma Awareness Month", unfortunately it comes and goes and most people don't even know.  If they do hear about it they think it is for skin cancer(Melanoma), not for the deadly blood cancer multiple myeloma. 
Picture
The National Cancer Institute publishes that  24% of the patients die in the first year whereas those in the care of a multiple myeloma specialist will have a survival rate of 95% or better.  This difference in the first year may be because of a lack of awareness, inadequate treatment, or misdiagnosis.  I have written an article called  "Why do People Die from Multiple Myeloma??  Lack of Awareness!!" and I am attaching it to this post as well.  At the end of the article I ask that people send this to their Facebook, Twitter, and other social media friends to get the word out about Multiple Myeloma, because I believe everyone either knows someone with Multiple Myeloma, or one of your contacts will know someone, and they could use your help. Maybe just maybe together we can SAVE LIFE. 


Why do people die from Multiple Myeloma? Lack of Awareness??????


When I ask the question it is more of a shout to the world --  because I feel that many people die sooner than they need to, and I just hate the thought of it!  I am just beside myself in understanding why there is such a difference between what is and what could be. That is the reason I started this blog in the first place.  The what could be is that many centers have patients who live for an average of 10 years or more, and the average life expectancy  for all multiple myeloma patients is just  4 years based on the most recent National Cancer Institute survival data.  So why the big gap between the two?

Some of it is understandable, because I have seen patients who have been given just decadron as their only care when I know this is just such a substandard treatment.  Then there is the patient who chose to only do holistic treatment.  Or the patient who chose no treatment, because his faith will heal him.   I, however, also have faith, but that faith is that my doctors will be guided by the hand of God.  This was their choice, and I can understand it, but I certainly do not agree with the choices, and unfortunately the outcomes were inevitable.   And one reader commented that it is caused by the lack of health insurance, and I agree that this has a an impact.  However, only 16.3% of the US population does not have health insurance and the differences are not 15 or 20% but 200 to 1000%.   So these cases I believe, are not the norm, and account for only a small amount of the difference.  I can only therefore submit to you that this difference must be in the quality of care.

There are a number of people who somehow seem to beat the odds.  Mike Katz, from the IMF(International Myeloma Foundation) is a 20-plus year survivor.  Does the fact that he is aware of all the latest and greatest myeloma discoveries weigh at all in his longevity?  Pretty dare good move Mike!  Or Barb Hammack(RIP) another 20-plus year survivor  from the myeloma  listserve(a patient to patient forum) who's doctor happens to have gone to school with Dr. Berenson.  And Dr. Berenson a myeloma specialist from LA has some of the best survival statistics in the world.  Are you starting to get the connection?    

The point here is that there is a big difference between the skills of a myeloma specialist, and that of your local oncologist.  Andrew Shorr of Patient Power had an interview with a Dr. Bensinger( a multiple myeloma specialist) and asked the question about whether patients should seek a second opinion.  His reply "I do think it's very important that patients with newly diagnosed myeloma consider a second opinion. And the reason is that this is not that common a disease. Despite the increased awareness of the disease in the community and among physicians, this is still a relatively rare disease. There's only about 17,000 new cases in the US. It's only one percent of all cancers and only ten percent of all blood cancers. And so it's a relatively uncommon disease, and I think there's so much new information out there that even practicing oncologists can't always keep up with the new information.  In addition, they should be made aware or least the patient should be made aware of possible trials that are available to them. That's how we've made all the progress in the treatment of this disease, is through clinical trials."  So if this belief exists in the Multiple Myeloma specialist community, then why is there still such a disparity in outcomes?  Sorry Folks, you got me? I can only speculate.  

Part of it may just be that the disease is just so rare that the dissemination of this information would never reach the light of day if not for organizations like the IMF(International Myeloma Foundation).  How many people know that March is Multiple Myeloma awareness month?  The IMF has been at the forefront of this education process, but unfortunately the National Cancer Institute numbers continue to lag those at the best institutions.  So if this life saving information is not reaching the myeloma patient community, how can we improve the awareness? 

In this day of the internet, Facebook and Twitter and other social media,  I therefore recommend that each of you send the following link to this page:
http://www.myelomasurvival.com/1/post/2013/03/save-life-march-is-multiple-myeloma-awareness-month.html   to all of your Facebook friends and Twitter followers, just to let them know that it is Multiple Myeloma Awareness Month and that a second opinion with a myeloma specialist could just "SAVE A LIFE".  I will almost guarantee that one of the people you send this to will know a Myeloma patient who could benefit from this information.   Because I have found that "Knowledge is power" and "Ignorance can kill!" 

For more information on multiple myeloma care and treatment go to www.myelomasurvival.com

God bless all who have to be on this journey/ [email protected]
5 Comments

Impressive Multiple Myeloma Life Expectancy and Survival Rate! & Cure?  -  The Arkansas Approach,  UAMS's Total Therapy 3,  by Gary Petersen and Priya Menon

2/21/2013

45 Comments

 
PictureUAMS - MIRT
There is probably not one subject of myeloma that has been debated more by so many in countless forums, and that is the subject of CURE for multiple myeloma.  And there is not one program or person that has been under the microscope more than the UAMS-MIRT(University of Arkansas for Medical Sciences - Myeloma Institute for Research and Therapy) program at Little Rock, Arkansas and the MIRT program director Dr. Bart Barlogie.   The first question might be why Little Rock?  What on earth could have happened to make Little Rock a focus of such Multiple Myeloma debate.

UAMS waiting room banter suggests it just could have been bad luck on the part of one very wealthy multiple myeloma patient.  Sam Walton of Walmart fame was diagnosed with myeloma, and went to M.D. Anderson in Houston, a world renowned cancer center.  His doctor at M.D. Anderson was Dr. Bart Barlogie.  Dr. Barlogie then established the world class MIRT(Myeloma Institute for Research and Therapy) at UAMS(University of Arkansas for Medical Sciences) just a stones throw away from Walmart's Bentonville, AR headquarters.  Coincidence? Wives' tale? Walton's money and influence? or UAMS's eye for talent and opportunity?   The story remains an integral part of the Little Rock lore.  However interesting this might be it is just not  true.  Since this article was first published UAMS assures me it was the latter and stated: " Dr. Barlogie came to Little Rock because he was offered the opportunity to take a leadership role in Hematology/Oncology research at the UAMS Cancer Institute and to ultimately build a program dedicated to research in/treatment of multiple myeloma and related diseases."  In addition, Barlogie has confirmed the UAMS account of this myth. 

Now for the sake of full disclosure, I was treated first at Mayo and then at UAMS, and I am like most patients who become vested in the program that they chose to follow.  It is for this reason, Priya Menon of Cure Talk was kind enough to co-author and edit this article and promised to keep it grounded and fact based.  Her take on the data and my analysis follows this segment.  I will not get into a debate about the UAMS claim of a 60% cure rate for the 85% of their patients that are considered low risk, however I will share the most recent data from the TT3 program with the multiple myeloma patient community.   I do happen to be one of the hopeful that pray it is true, and that my myeloma will never come back,

What is TT3 anyway?  It happens to be midway in the progression of clinical trial at UAMS that started with TT1, and then went on all the way to TT6.  The TT stands for Total Therapy and became well know as an approach that uses all available drugs in up front treatment for childhood leukemia(ALL) at St. Judes Children's Hospital.  The thought being that the best chance of eliminating all disease is at the beginning of treatment when the cancer has not been exposed to any drugs, and has not developed any resistant.   This approach has saved the lives of many children and has moved the cure rate from less than 10%  to  95% in childhood leukemia.  UAMS uses this same approach for multiple myeloma.    For TT3 it represents induction, two stem cell transplants, consolidation, and 3 years of maintenance, with the use of  the drug combinations VDT-PACE, Melphalan, and VTD.  A more in depth description of the protocol can found in a two part series by Nick Van Dyk and Pat Killingsworth called "Total Therapy Demystified" if you just click on PART1 and then PART2.

I often talk about a treatment continuum that goes from Dr. Berenson's "Less is Best" to Dr. Barlogie's "More is Cure", and therefore UAMS represents one extreme on this continuum.  What I have found is that the top 50 to 75 skilled multiple myeloma professionals in the world may have very different approaches to treatment, but all far outperform the published life expectancy and survival rate statistics.  And as you see on the home page of www.myelomasurvival.com Dr. Barlogie and Dr. Berenson have some of the very best results, and they have vastly different treatment philosophies. 


Picture
So how do the numbers for TT3 look.  If you tour the web you will find graphs that show TT3 results for 3 and sometimes 5 years, however when I was at my annual checkup in January at UAMS, Dr. Barlogie was kind enough to show me his most recent information on the 9 year Overall Survival for TT3.  The graph is as shown to the left.  More graphs of the TT3 data can be seen at the end of this article.  What it shows is an OS for 9 years of 64%, and a relative survival(multiple myeloma deaths only) of 75.7%.   This is no less than "OUTSTANDING" and maybe even Miraculous.  This data includes 15% high risk patients, and unfortunately most of the high risk patients will not have made it to 9 years, because no center has been able to unlock the key to high risk survival, and it remains at just over 2 years at UAMS. The National Cancer Institutes SEER data for 9 year relative survival is just 19.6%, therefore if you are under the care of Bart Barlogie at UAMS you are 3.3 times more likly to survive 9 years than at the average SEER faciltiy.  This is the best long term  life expectancy data yet provided to www.myelomasurvival.com.

So why isn't everyone using a TT3 type of protocol?    There are a number of reasons, some of which include the following.

1) Some people just don't believe the results are real!  This even when the results are being audited as required for all clinical trial studies. UAMS as a member of SWOG (Southwest Oncology Group) use the firm Cancer Research and Biostatistics
2) Many patients think that this can only be done at UAMS, where I would bet most of the 500 CIBMTR(Center for International Blood and Marrow Transplant Research)Transplant Hospitals are qualified to accomplish this protocol.
3) There are a number of programs that have excellent results and the patient may chose to select one that is championed by another skilled multiple myeloma professional.  Like the "Less is Best"  program of the IMBCR  or mSmart protocol of Mayo.
4) The TT3 protocol requires two stem cell transplants and not all patients are eligible for this procedure because of poor health or comorbidities.
5) Older patients may chose to not have a stem cell transplant and go the novel therapy route.
6) Many multiple myeloma specialists believe that the treatment is just too aggressive.
7) Insurance issues, like the fact Medicare will pay for only one Stem Cell Transplant, or a qualified center is not in your PPO network, or it is not an approved procedure. 

I would argue that as long as you have a skilled multiple myeloma professional on your team, and have access to a well established transplant program, that a TT protocol could be duplicated at many locations around the world.  However, I would add that the UAMS program is the location that initiated this protocol for MM, and has the most experience (over 10,000 transplants) with its application.


One thing that you will find is that there are a number of programs around the United States that most likely utilize a similar protocol or one that is more aggressive than the average program.  The reason is because the doctors at these locations obtained much of their multiple myeloma experience at UAMS, and under the tutelage of Dr. Barlogie.  These programs include the following:

Sundar Jagannath, MD - The Mount Sinai Medical Center, NY, NY
Jayesh Mehta, MD - Northwestern University Feinberg School of Medicine, Chicago, IL

David Siegel, MD - John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
Seema Singhal, MD - Northwestern Memorial Hospital, Chicago, IL
Guido Tricot, MD - University of Iowa Hospitals and Clinics,Iowa City, Iowa
David Vesole, MD - John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
Medical College of Wisconsin, Milwaukee, Wisconsin
Maurizio Zangari, MD -  Huntsman Cancer Institute, Salt Lake City, Utah

The data that Dr. Barlogie provided represents a conservative estimate of life expectancy in excess of 15 years, which is 3.8 times the published SEER life expectancy of 4 years.  The TT3 program had introduced the new novel agents of Velcade and Revlimid into the Total Therapy protocol and is a leap forward over the prior TT1 and TT2 treatment regimens.

Priya Menon provided the following take on this most recent TT3 data:

Total Therapy has been evolving for the past 20 years and has gone through several different protocols. TT3 protocol is significant since apart from its miraculous results, the protocol used two novel agents – Revlimid and Velcade at a time when these new drugs were saved to be used in the event of a relapse in other cancer centers.

Now, a little detailed look at TT3 protocol would put the current 9 years overall survival graph under scrutiny more in perspective and why we call it the Total Therapy. As Gary Petersen mentions,

Total Therapy 3 (TT3) combines an exhaustive multi-drug regimen with stem cell transplants. Patients are given two cycles of VTD-PACE; this is essentially Velcade (bortezomib), thalidomide, dexamethasone and continuous infusion of Cisplatin, doxorubicin, cyclophosphamide, and etoposide for 4 days. Two stem cell transplants with melphalan follow this. Consolidation therapy involves VTD-PACE and a total of 3 years of maintenance (first year with VTD, second and third year with TD).

We know that TT3 trial results were very encouraging and they had to be confirmed. For this, additional patients were enrolled in a TT3B trial in which the Velcade as maintenance therapy was administered for 3 years (instead of one) and Revlimid was used instead of thalidomide.

Myeloma patients were classified as low-risk or high-risk on the basis of their genes, and a difference in clinical outcomes were observed between low risk and high risk myeloma patients. 83% of participating patients were classified as low-risk myeloma patients and these patients demonstrated better OS, EFS, and CR in TT3 trials. Thus, without any doubt, TT3 is definitely a successful option for low-risk myeloma patients.

At 5 years, the overall survival reported in TT3 trials was 72%. The graph showing 64% overall survival at 9 years is truly phenomenal, pointing towards almost 15 years or more of life expectancy for the population under study. If the data includes both low risk and high-risk patients, this is definitely a significant treatment for myeloma patients. For the low risk population in the study, OS at nine years is 70%!

The high cure fractions observed in TT3 led to the design of TT4 protocol aimed at reducing dosage without compromising on achieved results TT5 for newly diagnosed high-risk patients, and TT6 for previously treated patients.

Now, only if UAMS were to be more open about sharing their data with outside evaluators, the scrutiny and suspicion that surrounds UAMS trial results would vanish and myeloma patients would have no qualms of considering UAMS TT protocols as a powerful therapy option.

All is not Roses however in the data, as was pointed out to me by Nick Van Dyk after this post was published. You can find Nick's extensive and exceptionally well written article at
the link:  http://nvdmyeloma.blogspot.com/2013/03/lies-damn-lies-and-statistics.html   I may blog about this subject myself in more detail at a later date.  One of the graphs below shows the CRD(Complete Response Duration) and previous graphs had shown them to have flattened out at 3 years which would indicate CURE.  However,  the new graph still shows a decline at 8 years, so the estimate for cure for this subset of low risk patients has yet to flatten out and confirm cure.  BUMMER!! 

Thank you Priya for helping me to provide a balanced analysis of the data.  A bio for Dr. Barlogie is below.

As always, may God Bless your myeloma journey/ Gary Petersen and Priya Menon




Picture
Bart Barlogie, M.D., Ph.D.

Director of the
UAMS Myeloma Institute

Professor of Medicine and Pathology

Tommy May Chair in Oncology
Director, Myeloma Institute


M.D. Heidelberg University, University of Munich 
Ph.D. Max Planck Institute for Medical Research 
Residency (internal medicine, hematology and infectious diseases, rheumatology, nephrology, cardiology, gastroenterology), University of Muenster. 
Clinical Fellowship (oncology), M.D. Anderson Hospital and Tumor Institute.

Numerous Professional Appointments at M.D. Anderson, including:

Professor of Medicine, Department of Hematology
Professor of Pathology, Department of Pathology
Chief, Section of Experimental Therapeutics, Department of Hematology
Chief, Cytometry Center, Department of Hematology

Honors and Awards:

Distinguished Alumnus Award – UT MD Anderson Cancer Center – 1998
Jan Waldenstrom Award for Myeloma Research – 1999
Celgene Career Achievement Award in Hematology Research – 2002
Robert A. Kyle Lifetime Achievement Award, International Myeloma Foundation – 2004
National Physician of the Year Award for Clinical Excellence, Castle Connolly Medical Ltd., 2006

Society Memberships:

American Society for Clinical Investigation
American Society of Clinical Oncology
American Society of Hematology
Association of American Physicians
International Society of Hematology
The American Society for Bone and Mineral Research

Additional Relevant Information:

Dr. Barlogie is an internationally recognized authority on the use of novel therapies to combat multiple myeloma for improved patient outcome. On the faculty at UAMS since 1989, Dr. Barlogie has built the largest center in the world devoted exclusively to clinical care for and research in multiple myeloma. More than 9,000 patients from every state in the U.S. and more than 50 countries have come to the Myeloma Institute. 

With a keen insight into the biology of myeloma, Dr. Barlogie pioneered the use of tandem peripheral stem cell transplant for multiple myeloma. Other firsts under Dr. Barlogie’s leadership include performing transplants on an outpatient basis, safely transplanting patients age 70 and older, transplanting patients with renal disease, and introducing thalidomide as anti-angiogenesis therapy. Dr. Barlogie’s Total Therapy approach, by which multiple agents are provided upfront, has continually increased median survival, with a projected median survival of 15 years for patients enrolled in the third Total Therapy protocol.

A consummate clinician scientist, Dr. Barlogie has authored more than 544 papers in prestigious journals such as Blood, New England Journal of Medicine, Journal of Clinical Oncology, British Journal of Haematology, and Cancer. He has more than 595 abstracts and 75 book chapters to his credit, and serves on the editorial board of numerous journals.


_

Picture
Picture
45 Comments

Multiple Myeloma - From a Patients Perspective - Cure Talk Broadcast  Feb. 28

2/19/2013

0 Comments

 

*** Now that the program has been aired you can listen to the rebroadcast if you CLICK HERE.***


Pat Killingsworth, blogger, author, and myeloma advocate will co-host with Priya Menon of Cure Talk the Myeloma Cure Panel broadcast  on the Feb. 28 @ 6:00pm EST.  It is a panel dedicated to answering the questions from patients and caregivers by panel members who are authors, bloggers, support group leaders, and living with multiple myeloma as well. 

Picture
The panel will include Gary Petersen, the editor of www.myelomasurvival.com, Nick Van Dyk, executive, musician, humorist, blogger and myeloma survivor, and Sandy Hirsch, myeloma survivor and founder and group leader of the Charlotte, NC myeloma support group.  All panelists will sum up their myeloma backgrounds and then the show would be open for questions. Listeners can ask questions to the panelists live on the show and should submit their questions prior to the show so the panelist can have an opportunity to research the topics if necessary.  You can view additional information about the program and register by just CLICKING HERE. Or if you would just like to register now just CLICK HERE.

If you would like to get a flavor of the backgrounds of each of the panel members your can go to the following blogs:

Pat Killingsworth - http://multiplemyelomablog.com/
Gary Petersen - www.myelomasurvival.com
Nick Van Dyk - http://nvdmyeloma.blogspot.com/
Sandy Hirst - www.charlotteobserver.com

We look forward to meeting and interacting with other members of the multiple myeloma patient and care giver community. 

P.S. -  Pat just recently published a blog post where Nick Van Dyk explained the UAMS or Arkansas approach to treatment called Total Therapy in an attempt to provide an even handed analysis of this well known approach to treatment.  It is well worth the read.  It is in a two part post. Just click on PART1 and PART2.

Best Regards and may God Bless your myeloma journey/Gary





0 Comments

There is a NEW FUTURE in Multiple Myeloma Treatments - Survival Rates and Life Expectancy Surge Forward!

2/3/2013

5 Comments

 
The cure panel discussion on New Promising Treatments for Multiple Myeloma was broadcast live on January 30 and featured Dr. Shaji K. Kumar from Mayo Clinic Rochester and Dr. Edward A. Faber Jr. of the University of Nebraska Medical Center.  These exceptional multiple myeloma specialists presented data on the recent ASH (American Society of Hematology) meeting.  Both of their programs are known for exceptional survival rates and life expectancy.  The rebroadcast can be heard if you just CLICK HERE.

Dr. Shaji Kumar led the presentation, with what I can only call a knock- out punch, that set the stage for all that followed.  His first remarks centered on a recent presentation that Mayo provided at ASH that showed the tremendous progress in survival rates and life expectancy that the currently approved FDA novel agents and newer treatments have provided in just 5 short years at the Mayo Clinic.  This data represents the progress that was made with the older approved novel agents of Velcade, Revlimid, and Thalidomide, and excludes any of the most recent novel agents of Carfilzomib and Pomalidomide, and all the other agents that Dr. Kumar and Dr. Faber addressed during this broadcast. 

Picture
Mayo Clinic conducted a retrospective study of all of their multiple myeloma patients.  The five year survival rates for the 2001-2005 period was about 48%, while the 2006-2010 period had a five year survival of 68%.  You are therefore 1.625 times more likely to survive for 5 years in the second period vs. the first period. This is a far cry from the prior study of patients between 1985-1998 when Dr. Kyle of Mayo stated that the survival had not changed at all during this period and remained at 33 months.  If you look at the data for the 2001-2005 periods, the average survival or life expectancy was very close to 5 years.  So the first 5 year period of 2001-2005 you would live 1.81 times longer than in the period of Dr. Kyle's study.  And the average survival rate has not been reached as yet for the 2006-2010 period.  This is nothing less than remarkable strides in survival rates and life expectancy at Mayo and I would argue at all other facilities like Dr. Faber's  University of Nebraska Medical Center who have a skilled multiple myeloma specialist on staff.  Unfortunately this improvement has not as yet shown up in the National Cancer Institutes SEER data,  but hopefully will in the near future.    The SEER data is about three years behind, with 2008 as their most recent data. 

All of the information on Promising New Treatments by Dr Kumar and Dr. Faber has yet to be reflected in the improvement in the Mayo data.  The doctors each presented information that showed the new treatments, and these treatments show additional promise and will drive the life expectancy higher and higher.  The Cure Panel discussion of Promising New Treatments began with Dr. Kumar discussing the new iMiD's and proteasome inhibitors.  These included Pomalidamide , Carfilzomib, and MLN9708.  In addition, Dr. Kumar discussed the new combination therapies substituting Carfilzomib and Pomalidamide in the RVd regiment.

Dr. Faber discussed the newest drugs under development for multiple myeloma that include drugs that target different pathways and other classes of drugs.  They included a KSP inhibitor, Daratumumab, BTK inhibitor, and BAFF-1 inhibitor.  Dr. Faber also talked about some of the very promising research coming from the combination of the same class of drugs like Revlamid and Thalidomide.  Both are iMiDs, but found to work well in combination.  Dr. Faber did an exceptional job in presenting this new data in a manner that was understandable and patient friendly.  Priya Menon of Cure Talk provided a nice summary of the broadcast at the link:  http://trialx.com/curetalk/2013/01/myeloma-patients-living-longer-the-cure-panel-talk-show-with-dr-shaji-k-kumar-and-dr-edward-a-faber/  Pat Killingsworth, a panel member and author, had a recent blog post with his takeaways from the broadcast and you can find it at the link: http://multiplemyelomablog.com/2013/01/myeloma-cure-talk-broadcast-focuses-on-emerging-myeloma-therapies.html 

Dr. Faber and Dr. Kumar not only provided us with this valuable information, but professionally and clearly answered all of the panel's questions, as well as all the questions asked by the listeners.  Please do listen to the broadcast, I think you will see your NEW FUTURE, and it is brighter.

And as always may God Bless your myeloma journey/Gary Petersen [email protected]



For more information on multiple myeloma go to www.myelomsurvival.com


5 Comments

What does Mesothelioma and Myeloma have in common - Stories of love and miracles!

1/28/2013

1 Comment

 
Picture
Look at this beautiful family!  They look happy and without a care in the world.  They are happy, committed to each other, loving, and in the fight of their lives.  Heather Von St. James has Mesothelioma(an incurable lung cancer), and she and her family have been in a fight that every myeloma patient is confronted with.  Mesothelioma has some of the same characteristics of myeloma that make their fight something that all  myeloma patients can relate with.

It is not common, but where myeloma has 20,000 newly diagnosed cases each year they have 2000, or it is 10 times less common.  Myeloma is incurable (our specialists are starting to question that), and Mesothelioma is incurable as well,but few question this assertion.  We have 50 to 75 multiple myeloma specialists in the USA that understand and are really qualified to adequately treat our disease, while they have 5 at best, and only one that is world renowned.  Our published life expectancy is 4 years, while mesothelioma has a life expectancy of just over one year from diagnosis.  So why the smiles on this loving family's faces?  Because in the face of these odds stacked against them they would fight this death sentence with all of their heart and soul, faith, and family.  This is the story of Heather, Cameron, and Lily.  Cameron has a caregiver blog at the link: http://www.mesothelioma.com/blog/authors/cameron/  This is their story as presented to me by Cameron, and I felt compelled to share it with each of you.


Taking Care of My Wife with Cancer (Cameron Von St. James)

The 21st of November is a day that will always stick in my head. It was that particular day that my wife, Heather, received a cancer diagnosis. We found out that Heather was suffering from mesothelioma. It was on that day that I became Heather’s caregiver. Becoming a caregiver for a person with cancer was not something I expected to be doing. Just a few months before Heather received her diagnosis, we were in celebration mode because our first child, Lily, had just been born. After Lily was born, our focus was on her and the upcoming holidays. We could not wait to spend Christmas with Lily, but the diagnosis turned our world upside down, and our focus shifted to beating this cancer.

After Heather received her diagnosis, the doctor started giving us more information on mesothelioma. The doctor said that Heather would need to go to a specialist in order to find out more information about treatment. We were told that Heather had several options, including a local hospital or a doctor, Dr. David Sugarbaker, who specializes in mesothelioma in Boston. Upon hearing these options, I looked at Heather’s face to see what option she would be interested in pursuing.  However, Heather appeared to be distraught. I jumped in and decided that seeing the specialist in Boston would be the best decision.


For the next few months things were quite difficult and chaotic. Life as we knew it had changed. Before Heather was diagnosed, she had returned back to work after having Lily. Both of us were working full-time positions. Once she received her diagnosis, Heather had to stop working and I began working only part-time. Aside from work, I was accompanying Heather to her appointments and caring for Lily. In just a short amount of time, things started to become extremely overwhelming for me. I also began to feel scared and afraid that my wife was going to pass away, leaving me a broke widower and single father, raising a daughter who would never really know her mother. I can admit that I broke down crying about these things on several occasions. I never allowed Heather to see me this way because I wanted to be strong so that she would feel strong too.

We received lots of support from our close friends and family members. There were even some strangers who were willing to help. I quickly learned to take the help that was being offered to me. The people who helped us also made me feel like I was not alone. I never realized how challenging being a caregiver could be until I actually became one. There is a lot of stress involved with being a caregiver. The best way to get through it all is to accept help and use as many resources available as possible. My life did not go back to what I consider normal for many years. There were a lot of challenges along the way, including Heather’s mesothelioma surgery, radiation treatments, and chemotherapy. There was a light at the end of the tunnel though, and Heather did overcome mesothelioma. Today, over seven years later, Heather is healthy and cancer-free.

I have learned a lot along the way. One of the most important things I learned was to live for the moment, which is why I chose to further my education in Information Technology. Learning to balance caring for Lily and my wife while working helped me to gain the courage to further my education and take that chance. In fact, I graduated from school with honors and was able to speak at the graduation. I would have never expected to be in that position just a few years ago. Learning to believe in myself played such an important role. Heather and Lily were in the audience to cheer me on, and that was the greatest reward of all.

The Minneapolis St. Paul Star Tribune also did an excellent article on the Von St. James family Meso journey and Heather's radical life saving surgery,  which you can read at:
http://www.startribune.com/local/east/27512374.html?refer=y   Healthy and Cancer Free, how truly wonderful is that?  As you can see they did the two most important things that anyone can do when confronted with an uncommon and incurable cancer.  They became their own best advocates, and researched all they could, and then found the absolutely best mesothelioma specialist in the country.  They stacked the deck in their favor as best they could and the result was miraculous.  Thank you for your story of love, commitment, and HOPE.  And as always, may God Bless your myeloma Journey/ Gary Petersen [email protected]

For more information on multiple myeloma go to www.myelomasurvival.com



1 Comment

Multiple Myeloma - The Longer You Live, The Longer You Live!  Survival Rate and Life Expectancy Improves to a Cure rate at 10 years of Survival 

1/20/2013

4 Comments

 
Some recent studies have shown that if a multiple myeloma patient can survive 10 years, they seldom relapse after this time and this could be considered cure.  This happens in about 10% of all cases.  This assertion has been repeated by Dr Berenson, Dr. Hari, and Dr. Vij on three separate Cure Panel Broadcasts. 

However, I think we can take this one step further.  For each year of survival, the probability of survival improves and continues to improve until it reaches the same survival rate for the general population of the same age.  An analysis of the SEER survival rates provided by the National Cancer Institute shows this exact relationship.  If I subtract the yearly survival rate of year 0 from year one,  I find that 23.5 percent of all multiple myeloma patients do not survive, and if I do this for year 1 to year 2 then 10.9 percent of the total patients do not survive for this period.  You can continue this process all the way to the period between year 9 and year 10 where only 2.1 percent of the patients do not survive during this period.  At this point the Social Security Life Expectancy tables report that the average American will die at a rate of 2.15 percent, or at a rate slightly greater rate than the average multiple myeloma patient.  So "The longer you live, The longer you live!"


Picture
Picture
There are a number of possible explanations for this relationship.  Some may be early deaths for high risk patients, smoldering patients, the advent of the use of novel agents, some patients obtaining and maintaining CR, et al.  However, the newest data that I have seen from the multiple myeloma specialists show 1 and 2 year rates that are much better by 2 to 13 times the rates provided by SEER.  In addition, this SEER data represents an average life expectancy of 4 years where many of the multiple myeloma specialists have average life expectancy of 7 to 10 years. 

So the best three things that you can do to improve life expectancy remain "Multiple Myeloma Specialist, Multiple Myeloma Specialist, and Multiple Myeloma Specialist."   A listing of the world's best can be found at the link: http://www.myelomasurvival.com/myeloma-specialists-listing.html.  



4 Comments

Multiple Myeloma Specialist Jan Moreb MD of the University of Florida Shands is recognized for exceptional multiple myeloma survival

1/17/2013

0 Comments

 
Picture
Dr. Jan Moreb, right, visits with patient Jerry Fadely, Erica Brough/The Gainesville Sun
Dr. Jan Moreb, a Multiple Myeloma Specialist from Shands at the University of Florida was the subject of a Gainesville Sun article which highlighted his myeloma treatment program.  Kristine Crane a staff writer at the Gainesville Sun provides an excellent article which highlight the superior survival rate and life expectancy of the patients under Dr. Moreb's care.  Kristine interviewed the editor of  Myelomasurvival.com as part of this article, and we were very pleased to be part of this excellent article.   You can find the entire article at this link: http://www.gainesville.com/article/20130106/ARTICLES/130109795?p=1&tc=pg 

Kristine providing the following explanation of the treatment philosophy of Dr. Moreb,  She explains, "He is known for a more conservative approach to treating patients by using chemotherapy drugs sequentially instead of all at once.“Since cancer cells typically become resistant to chemotherapy, by exposing them to drugs one by one, instead of all at once, there is a greater likelihood that the effects of the drugs will last longer,” Moreb said.

Some specialty centers around the country employ the drugs all at once, but Moreb said that not only increases patients' drug resistance in the case of relapse, which is typical in myeloma patients, it also heightens patients' exposure to the toxic side-effects of the drugs, which can be fatal.

Multiple myeloma patients also typically undergo one stem cell transplant — in which healthy bone marrow stem cells are extracted from the patient's bloodstream and re-injected or transfused back into the bloodstream — after the chemotherapy has killed as many of the cancerous cells as possible.

At some centers, patients automatically undergo two transplants, just a few months apart. Moreb collects enough stem cells for two transplants but freezes the cells intended for a second transplant, which is performed only if the patient relapses, he said. This more moderate approach saves patients from experiencing too much too soon, he said."

Best regards and may God Bless your Myeloma journey/ Gary Petersen editor@myeloma survival.com










0 Comments
<<Previous
Forward>>

    Author

    Gary R. Petersen
    [email protected]
    CLICK HERE for my myeloma journey

    ©2012 All Rights Reserved

    Categories

    All

    Archives

    January 2025
    August 2023
    March 2023
    October 2022
    February 2021
    October 2020
    September 2020
    August 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    August 2018
    June 2018
    May 2018
    April 2018
    January 2018
    November 2017
    October 2017
    September 2017
    August 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    May 2013
    April 2013
    March 2013
    February 2013
    January 2013
    December 2012
    November 2012
    October 2012
    September 2012
    August 2012
    July 2012
    June 2012
    May 2012
    April 2012
    March 2012

    RSS Feed

Web Hosting by iPage